July 26, 1991 |
Quotron Target of Suits: Two Canadian stock exchanges filed lawsuits accusing Quotron Systems Inc., a major distributor of financial information, of misusing data provided by the exchanges. The Toronto Stock Exchange and Montreal Stock Exchange sought a total of $53 million in damages and restitution for alleged breach of contract and fraud in use of market data from 1985 to 1989.
March 28, 1997 |
Canada's Toronto stock market, the country's largest, posted its biggest intra-day drop in almost a decade Thursday as shares in former market darling Bre-X Minerals Ltd. took a beating. The Toronto Stock Exchange's key 300 composite index plummeted 191.21 points to 5,931.63, its biggest loss since October 20, 1987, the day after so-called Black Monday, when it lost 220.90 points.
April 1, 1997
Canadian mining company Bre-X Minerals Ltd. asked the Toronto Stock Exchange to halt trading of its shares until further tests resolve the furor over its claims about a huge gold discovery in Indonesia. A class-action lawsuit was filed in New York on behalf of Bre-X investors, alleging that its executives sold shares before serious questions over the gold find sent the stock into a nose dive. . . . Republic Industries Inc. said Chairman H.
May 20, 1995 |
Labatt Seeks White Knight to Fight Takeover: The Canadian brewing company vowed to fend off a hostile $1.7-billion takeover by conglomerate Onex Corp., saying it is talking to several parties and expects a better offer to emerge. John Labatt Ltd.'s board was huddled in Toronto, kicking off what analysts believe is a frantic search for a white knight.
December 26, 1989 |
U.S. trading in the stock of Campeau Corp., which was halted Friday, did not resume today because the Toronto Stock Exchange was closed for a holiday, an official at the National Assn. of Securities Dealers said. Toronto-based Campeau disclosed Friday that its bankers believe it has technically defaulted on $2.34 billion in debt. The retailer's stock is traded on the Toronto exchange as well as on the U.S. over-the-counter market.
May 27, 2013 |
Valeant Pharmaceuticals International Inc., Canada's largest publicly traded drug maker, is continuing an acquisition spree with an agreement to buy eye-care giant Bausch & Lomb Holdings Inc. for $4.5 billion. The Montreal company, which announced the deal Monday, said it also would pay $4.2 billion in debt owed by privately held Bausch & Lomb, a major manufacturer of contact lenses. Calling Bausch & Lomb a “world-renowned brand,” Valeant's chairman and chief executive, J. Michael Pearson, said the deal would “transform Valeant into a global leader in eye health.” GALLERY: Biggest Southern California companies Valeant said it expects to squeeze out $800 million in annual cost savings by the end 2014 after merging Bausch & Lomb, which is based in Rochester, N.Y., with Valeant's much smaller eye-care operations.